CD 4 Clinical Research

CD 4 Clinical Research

1st Clinically proven: Promote CD4 cell product

** Muhimbili University College of Health Sciences, Tanzania, randomized clinical trial for 6 months, 3 capsules/day.

What is CD4? : Another name for a "helper" T-cell, a type of white blood cell. A measurement of the strength of your immune system. The higher your CD4 cell count, the stronger your immune system. These cells protect your body from germs that can cause infections and diseases.

What is Hb: haemoglobin? : The part of the red blood cells that carries oxygen to the cells from the lungs and carbon dioxide away from the cells to the lungs.

OBJECTIVE: To determine the efficacy of the Lingzhi mushrooms in the treatment of low immunity patients: (1) the effect of Lingzhi treatment on CD4 count, haemoglobin (HB) and some clinical opportunistic infections, and general well being of low immunity patients; and (2) the comparative efficacy of ARV (anti-retroviral) drugs alone, and in combination with Lingzhi mushrooms3.

METHOD: This project is supported by UNDP/UNOPS/UNAIDS (United Nation) and is being conducted in 7 sites with around 50 patients each across Swaziland, Tanzania and Zambia. The results of one site in Tanzania are reported here. Clinical testing trials comprise of three sets of patients, who had CD4 counts between 100 and 200 at registration, in each site: one on ARV only; the second on ARV in combination with Lingzhi; and the third on Lingzhi only. In all cases, dosages of Lingzhi are 6-9 x 120mg capsules per day.

RESULT: The studies are still progressing; however there is evidence that low immunity associated oral thrush infections healed within 3 to 7 days of taking Lingzhi. Patients’ progress, after three months, in one site was released from Tanzania, see following Table. In addition, patients’ skin complexion improved, their warts disappeared, and patients themselves personally reported a significant health improvement.
Results: Concord Sunchih can effectively increase CD4 cell & HB

A. ARV +
Ganoderma
B. ARV +
Placebo
ARV only​

No. of patients

22
13
11​

Average body weight increase

4.8kg
3.7kg
1.3kg​

Average CD4 count increase

136 cells
74 cells
66 cells​

Average HB increase

1.1 mg
0.4 mg
0.7 mg​

CD4

CONCLUSION: Lingzhi has been demonstrated to be effective in enhancing the immuno-response. Our preliminary clinical testing trials of Ganoderma lucidum on low immunity patients have generated very intriguing results, in terms of: stimulating body weight increases of the treated patients; increases in CD4 counts, increases in haemoglobin levels; enhanced smoothness of the skin of the patients; and improvements in general body fitness. However, Ganoderma ( Lingzhi) products should be considered as dietary supplements / nutriceuticals rather than drugs for low immunity patients in Africa.

By using Lingzhi to increase the CD4 cell count, the stronger your immune system. These cells protect your body from germs that can cause infections and diseases. More patients should by using as a support medicine.

3 Provided by Concord Health Australia, Sydney.
http://www.concordhealth.com.au/ind...9549609-0826&gclid=COudgM6R_qACFQ6Y2AodujrulQ

Click to expand...

ngoshwe said:

Hivi, tokea UKIMWI uanze ile miaka ya 80's. mpaka hii leo hakuna matokeo yanayoridhisha ya utafiti wa tiba au hili gonjwa au ndo lishakuwa la kiuchumi na kibiashara zaidi?

Kwa muda mrefu sasa, taarifa za utafiti wa kisayansi ambazo zinaendelea kutumia mabiliono ya fedha za umma zinaoekana kana kwamba hazina uhakika kamili na matokeo ya tafiti japo sehemu nyingine, wapo wataalamu wanaothibitisha kuwepo kwa dawa za kuponya kabisa au kurekebisha "masumbufu" ya kiafya ya ili gonjwa hatari kwa jamii.

Click to expand...